Identifying the facilitators and barriers to implementation of renal tumour biopsy in the diagnostic pathway for small renal masses

Author:

Ranieri Veronica1ORCID,Warren Hannah23ORCID,Florez Isabella3,Neves Joana B.23,Walkden Miles4,Bernstein Darryl E.23,Santiapillai Joseph23,Williams Norman2,Wildgoose William H.5,Patki Prasad3,Stewart Grant D.6ORCID,Kinsella Netty7,Pizzo Elena8,Barod Ravi23,Bex Axel23,Mumtaz Faiz23,El‐Sheikh Soha3,Gurusamy Kurinchi2,Tran Maxine G.B.23ORCID

Affiliation:

1. Department of Science, Technology, Engineering and Public Policy (STEaPP) University College London London UK

2. Division of Surgery and Interventional Sciences University College London London UK

3. Specialist Centre for Kidney Cancer Royal Free Hospital London UK

4. Department of Interventional Radiology University College Hospital London UK

5. Patient Representative London UK

6. Department of Surgery University of Cambridge Cambridge UK

7. Urology Unit The Royal Marsden NHS Foundation Trust London UK

8. Research Department of Primary Care and Public Health London UK

Abstract

ObjectivesTo understand the facilitators and barriers to the implementation of renal tumour biopsy (RTB) in the diagnostic pathway for renal tumours in England.Patients and MethodsParticipants consisted of patients who had a renal tumour diagnosed and/or treated at one of five tertiary centres in England, healthcare professionals involved in the direct care of patients diagnosed with renal tumours, and clinical service managers and commissioners. The study employed a mixed‐methods research methodology consisting of individual interviews and an on‐line survey that explored the types of facilitators and barriers individuals perceived and experienced and the frequency in which these were reported. A public dissemination event took place following the completion of data collection; to facilitate discussion of potential solutions to implementing RTB.ResultsThere were 50 participant interviews (23 patients, 22 clinicians, and five health service commissioners/operations managers). The patient on‐line survey received 52 responses, and the clinician survey received 22 responses. Patients most frequently reported influences in choosing whether to undergo RTB pertained to wanting to know the diagnosis of their kidney mass (40%), the advice or information provided by healthcare professionals (40%), and not wishing to delay treatment (23%). Clinicians most frequently reported barriers to recommending RTB related to their uncertainty of diagnostic accuracy (56%), availability of appointments or hospital beds (52%), concerns of risk of bleeding (44%), risk of seeding (41%), and delays in meeting national cancer pathway targets (41%). The dissemination event was attended by 18 participants (seven patients and 11 clinicians). Suggestions to improve implementation included reducing variation and promotion of standardisation of practice by a consensus statement, increasing the evidence base (clinicians) and improved communication by developing better patient aids such as videos and diagrams (patients and clinicians).ConclusionImplementation of RTB may be dependent on the quality of information provided, its format and perceived reliability of the information. Increased utilisation of RTB may be improved by development of a consensus statement on the role of biopsy, with patients expressing a preference for alternative information aids such as patient videos.

Publisher

Wiley

Reference30 articles.

1. Regional Variation of Computed Tomographic Imaging in the United States and the Risk of Nephrectomy

2. Uncoupling Diagnosis and Treatment of Incidentally Imaged Renal Masses

3. Incidental small renal tumours: are we performing unnecessary surgery?

4. Cancer Research UK.Kidney Cancer Statistics. Cancer Research UK 2024. Available at:https://www.cancerresearchuk.org/health‐professional/cancer‐statistics/statistics‐by‐cancer‐type/kidney‐cancer#heading‐Four. Accessed 23rd May 2024

5. The impact of tumor size on the survival of patients with small renal masses: A population–based study

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3